Behzad Aghazadeh, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 686,820 shares at $73.00 ($50.1M) on 2019-02-20, disclosed to the SEC on 2019-02-21.
Open-market sale of $50.1M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMMU | BUY | 2019-12-09 | $35.0M | — | Filing → |
| MRTX | SELL | 2019-07-25 | $6.4M | — | Filing → |
| MRTX | SELL | 2019-03-20 | $27.7M | — | Filing → |